AAAAAA
Results:
1-9
|
Results: 9
Authors:
Op de Coul, ELM
Prins, M
Cornelissen, M
van der Schoot, A
Boufassa, F
Brettle, RP
Hernandez-Aguado, I
Schiffer, V
McMenamin, J
Rezza, G
Robertson, R
Zangerle, R
Goudsmit, J
Coutinho, RA
Lukashov, VV
Citation: Elm. Op De Coul et al., Using phylogenetic analysis to trace HIV-1 migration among western European injecting drug users seroconverting from 1984 to 1997, AIDS, 15(2), 2001, pp. 257-266
Authors:
Sarcletti, M
Petter, A
Romani, N
Lhotta, K
Konig, P
Maier, H
Zangerle, R
Citation: M. Sarcletti et al., Pyuria in patients treated with indinavir is associated with renal dysfunction, CLIN NEPHR, 54(4), 2000, pp. 261-270
Authors:
Babiker, A
Darby, S
De Angelis, D
Kwart, D
Porter, K
Beral, V
Darbyshire, J
Day, N
Gill, N
Coutinho, R
Prins, M
van Benthem, B
Coutinho, R
Dabis, F
Marimoutou, C
Ruiz, I
Tusell, J
Altisent, C
Evatt, B
Jaffe, H
Kirk, O
Pedersen, C
Rosenberg, P
Goedert, J
Biggar, R
Melbye, M
Brettie, R
Downs, A
Hamouda, O
Touloumi, G
Karafoulidou, A
Katsarou, O
Donfield, S
Gomperts, E
Hilgartner, M
Hoots, K
Schoenbaum, E
Beral, V
Zangerle, R
Del Amo, J
Pezzotti, P
Rezza, G
Hutchinson, S
Day, N
De Angelis, D
Gore, S
Kingsley, L
Schrager, L
Rosenberg, P
Goedert, J
Melnick, S
Koblin, B
Eskild, A
Bruun, J
Sannes, M
Evans, B
Lepri, AC
Sabin, C
Buchbinder, S
Vittinghoff, E
Moss, A
Osmond, D
Winkelstein, W
Goldberg, D
Boufassa, F
Meyer, L
Egger, M
Francioli, P
Rickenbach, M
Cooper, D
Tindall, B
Sharkey, T
Vizzard, J
Kaldor, J
Cunningham, P
Vanhems, P
Vizzard, J
Kaldor, J
Learmont, J
Farewell, V
Berglund, O
Mosley, J
Operskalski, E
van den Berg, M
Metzger, D
Tobin, D
Woody, G
Rusnak, J
Hendrix, C
Garner, R
Hawkes, C
Renzullo, P
Garland, F
Darby, S
Ewart, D
Giangrande, P
Lee, C
Phillips, A
Spooner, R
Wilde, J
Winter, M
Babiker, A
Darbyshire, J
Evans, B
Gill, N
Johnson, A
Phillips, A
Porter, K
Lorenzo, JI
Schechter, M
Citation: A. Babiker et al., Time from HIV-1 seroconversion to AIDS and death before widespread use of highly-active antiretroviral therapy: a collaborative re-analysis, LANCET, 355(9210), 2000, pp. 1131-1137
Authors:
Petter, A
Heim, K
Guger, M
Ciresa-Konig, A
Christensen, N
Sarcletti, M
Wieland, U
Pfister, H
Zangerle, R
Hopfl, R
Citation: A. Petter et al., Specific serum IgG, IgM and IgA antibodies to human papillomavirus types 6, 11, 16, 18 and 31 virus-like particles in human immunodeficiency virus-seropositive women, J GEN VIROL, 81, 2000, pp. 701-708
Authors:
Sarcletti, M
Zangerle, R
Citation: M. Sarcletti et R. Zangerle, Persistent flank pain, low-grade fever, and malaise in a woman treated with indinavir, AIDS PAT CA, 13(2), 1999, pp. 81-87
Geographical variation in disease progression in HIV-1 seroconverted injecting drug users in Europe?
Authors:
Prins, M
Brettle, RP
Robertson, JR
Aguado, IH
Broers, B
Carre, N
Goldberg, DJ
Zangerle, R
Coutinho, RA
van den Hoek, A
Citation: M. Prins et al., Geographical variation in disease progression in HIV-1 seroconverted injecting drug users in Europe?, INT J EPID, 28(3), 1999, pp. 541-549
Authors:
Prins, M
Robertson, JR
Brettle, RP
Aguado, IH
Broers, B
Boufassa, F
Goldberg, DJ
Zangerle, R
Coutinho, RA
van den Hoek, A
Citation: M. Prins et al., Do gender differences in CD4 cell counts matter?, AIDS, 13(17), 1999, pp. 2361-2364
Authors:
Muhlbacher, M
Spruth, M
Siegel, F
Zangerle, R
Dierich, MP
Citation: M. Muhlbacher et al., Longitudinal study of antibody reactivity against HIV-1 envelope and a peptide representing a conserved site on gp41 in HIV-1-infected patients, IMMUNOBIOL, 200(2), 1999, pp. 295-305
Authors:
Gruber, A
Speth, C
Lukasser-Vogl, E
Zangerle, R
Borg-von Zepelin, M
Dierich, MP
Wurzner, R
Citation: A. Gruber et al., Human immunodeficiency virus type 1 protease inhibitor attenuates Candida albicans virulence properties in vitro, IMMUNOPHARM, 41(3), 1999, pp. 227-234
Risultati:
1-9
|